Correlation Between COSCIENS Biopharma and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both COSCIENS Biopharma and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining COSCIENS Biopharma and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between COSCIENS Biopharma and Apogee Therapeutics, Common, you can compare the effects of market volatilities on COSCIENS Biopharma and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in COSCIENS Biopharma with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of COSCIENS Biopharma and Apogee Therapeutics,.
Diversification Opportunities for COSCIENS Biopharma and Apogee Therapeutics,
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between COSCIENS and Apogee is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding COSCIENS Biopharma and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and COSCIENS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on COSCIENS Biopharma are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of COSCIENS Biopharma i.e., COSCIENS Biopharma and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between COSCIENS Biopharma and Apogee Therapeutics,
Given the investment horizon of 90 days COSCIENS Biopharma is expected to generate 1.33 times more return on investment than Apogee Therapeutics,. However, COSCIENS Biopharma is 1.33 times more volatile than Apogee Therapeutics, Common. It trades about 0.06 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.11 per unit of risk. If you would invest 335.00 in COSCIENS Biopharma on October 9, 2024 and sell it today you would earn a total of 28.00 from holding COSCIENS Biopharma or generate 8.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
COSCIENS Biopharma vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| COSCIENS Biopharma |
| Apogee Therapeutics, |
COSCIENS Biopharma and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with COSCIENS Biopharma and Apogee Therapeutics,
The main advantage of trading using opposite COSCIENS Biopharma and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if COSCIENS Biopharma position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| COSCIENS Biopharma vs. Alaska Air Group | COSCIENS Biopharma vs. Arrow Electronics | COSCIENS Biopharma vs. Tencent Music Entertainment | COSCIENS Biopharma vs. Warner Music Group |
| Apogee Therapeutics, vs. Ginkgo Bioworks Holdings | Apogee Therapeutics, vs. CureVac NV | Apogee Therapeutics, vs. Iovance Biotherapeutics | Apogee Therapeutics, vs. Krystal Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |